A total of eight products were added in the month from six different asset managers: Matthews, Eurizon, Allianz, JPMorgan, Genstar Capital and Valor Management.
Andean AFPs hope improving economies will negate need for further withdrawals
A third withdrawal in Chile or in Peru does not have sufficient support at this time but, once the economic effect of the previous withdrawals is over, the situation could change.
CCR Monthly Approval Report – January 2021
HSBC, Aviva Investors, Dimensional, Federated Hermes, Morgan Stanles, Pictet, WisdomTree, Aberdeen Standard and, Berkshire Partners were the managers registering products in January 2021.
Will 2021 be a breakout year for active funds in Mexico? The Amafore seems to think so.
The Amafore's Alvaro Melendez predicted an uptick in allocations to active funds while emphasizing need to increase cap on international investments.
Felices y Forrados in the spotlight as Chilean regulators aim to limit transfers
A government proposal would limit movements between non-adjacent multifunds, while Congress will also examine the role of unregulated advisors.
CCR Monthly Approval Report – December 2020
Columbia Threadneedle led the list of registered products with 14 mutual funds, followed by Samsung with four ETFs, and Aviva, Credit Suisse and Altis each with one product approved of their own.
AFPs: Wave of reforms sweeps Chile and Peru
Along with approving the withdrawal of funds to fend off economic hardships caused by the pandemic, deep reforms are being discussed in both countries.
CCR Monthly Approval Report – November 2020
UBAM, Schroder, Axa, AZ Fund, Legg Mason, Lyxor, Pinebridge, DWS, Harrison Street and Kohlberg Kravis Roberts & Co. were the fund sponsors gaining approval for new products.
CCR Monthly Approval Report – October 2020
Berenberg, Candriam, Credit Suisse, Ninety One, UBS, iShares, State Street, Crow Holdings, Goldman Sachs and TCV were the fund sponsors gaining approval for new products listed on the month.